https://www.selleckchem.com/products/sr4370.html
n. Guidelines emphasize prompt antiviral treatment in severe influenza patients. Although nearly a 50% of severe influenza present with pneumonia, the effect of early (≤ 2 days after illness onset) neuraminidase inhibitor (NAI) use on the clinical outcomes of influenza A-related pneumonia (FluA-p) has rarely been assessed. Furthermore, data about the administration of NAIs in the real-world management of Flu-p in China are limited. Data of patients hospitalised with FluA-p from five teaching hospitals in China from 1 January 2013 to 31 D
Like
Comment
Share
